Mexico Catheters Market Size, Share, Trends, Growth Factors and Forecast Report by 2026-2034
IMARC Group has recently released a new research study titled “Mexico Catheters Market Size, Share, Trends and Forecast by Product Type, End User, and Region, 2026-2034” which offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.
Market Overview
The Mexico catheters market size was valued at USD 381.74 Million in 2025 and is projected to reach USD 681.58 Million by 2034, growing at a compound annual growth rate (CAGR) of 6.65% during the forecast period of 2026-2034. Growth is driven by the rapidly aging population and increasing prevalence of cardiovascular diseases, diabetes, and chronic kidney conditions. Government investments in hospital infrastructure and adoption of minimally invasive surgical procedures further stimulate demand for advanced catheter technologies.
Study Assumption Years
● Base Year: 2025
● Historical Year/Period: 2020-2025
● Forecast Year/Period: 2026-2034
Mexico Catheters Market Key Takeaways
● The Mexico catheters market size was USD 381.74 Million in 2025.
● The market is expected to grow at a CAGR of 6.65% from 2026 to 2034.
● Forecast revenue is projected to reach USD 681.58 Million by 2034.
● Cardiovascular catheters dominated the market with 28% share in 2025 due to a high burden of heart disease.
● Hospitals and clinics accounted for the largest end-user share of 71% in 2025, driven by their infrastructure and expertise.
● The market features a competitive landscape with multinational corporations and regional distributors leveraging strong networks and manufacturing capabilities.
● Government healthcare expansions, including new hospitals and clinics, support growing catheter demand.
Sample Request Link: https://www.imarcgroup.com/mexico-catheters-market/requestsample
To get more information on this market, Request Sample
Mexico Catheters Market Growth Factors
Rising prevalence of cardiovascular diseases and chronic conditions is a major growth driver for the Mexico catheters market. In 2024, cardiovascular diseases accounted for approximately 192,518 deaths, making them the leading cause of mortality in Mexico. High rates of hypertension affecting about 29.4% of adults and widespread diabetes fuel demand for diagnostic and therapeutic catheter procedures. Hospitals and specialty centers are expanding catheterization labs to handle increasing patient volumes which supports timely diagnosis and minimally invasive treatments.
Government investments in healthcare infrastructure expansion further stimulate market growth. The Mexican government is actively building new hospitals, modernizing older facilities, and upgrading surgical departments to accommodate advanced treatment technologies. Public institutions such as IMSS play a central role by increasing access to specialized care across regions. These initiatives enhance catheter-based procedure adoption, improve service delivery in underserved areas, and support integration of modern medical devices in clinical practice.
Demographic shifts, particularly an aging population, are also significant drivers. The population aged 65 and older reached roughly 9.68% in 2024—a historic high. Older adults have higher prevalence of cardiovascular diseases, urinary complications, and chronic conditions requiring regular catheter use. Healthcare providers are adapting care models for elderly patients needing ongoing monitoring and minimally invasive interventions. This demographic trend is increasing demand for catheter products across Mexico.
Mexico Catheters Market Segmentation
Product Type:
● Cardiovascular Catheters: Lead with a 28% market share in 2025, driven by the high heart disease burden in Mexico and increased adoption of minimally invasive cardiac interventions.
● Urology Catheters: Not specifically detailed but included as a key product type.
● Intravenous Catheters: Included among product types.
● Neurovascular Catheters: Included among product types.
● Specialty Catheters: Included among product types.
● Others: Represent the remaining catheter product categories.
End User:
● Hospitals and Clinics: Leading segment with 71% market share in 2025, due to their infrastructure, specialized personnel, and procedures.
● Ambulatory Surgical Centers: Included as an end-user category.
● Others: Encompass additional healthcare facility types.
Region:
● Northern Mexico: Significant market with advanced healthcare infrastructure in industrial border cities like Monterrey and Tijuana, benefiting from proximity to US medical practices and a growing medical tourism sector.
● Central Mexico: Anchored by Mexico City metropolitan area, with major hospitals, specialized centers, and leading interventional cardiology programs.
● Southern Mexico: Emerging growth opportunities, though with less advanced infrastructure compared to northern and central regions. Government initiatives aim to improve access.
● Others: Other regions with evolving healthcare systems and regional medical centers contributing to market growth.
Regional Insights
Northern Mexico is a dominant region in the Mexico catheters market, characterized by advanced healthcare infrastructure and industrial cities along the border. The proximity to United States medical practices, developed hospital networks in cities like Monterrey and Tijuana, and a growing medical tourism sector attract patients seeking catheter-based procedures. This region holds a significant market position due to these factors.
Speak to an Analyst: https://www.imarcgroup.com/request?type=report&id=33402&flag=C
Recent Developments & News
In May 2025, Quasar Medical announced its acquisition of Nordson MEDICAL’s design and development business, including the Tecate facility in Mexico. This acquisition strengthens Quasar’s global CDMO capabilities and its position in catheter and interventional device manufacturing. In September 2025, Nordson Corporation confirmed the divestiture of its contract-manufacturing design and development units to Quasar Medical, allowing Nordson MEDICAL to focus on its proprietary medical-component portfolio while enhancing Quasar’s CDMO operations.
Key Players
● Sahajanand Medical Technologies (SMT)
● Bactiguard
● Quasar Medical
● Nordson MEDICAL
● Nordson Corporation
Customization Note
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us
IMARC Group,
134 N 4th St. Brooklyn, NY 11249, USA,
Email: [email protected],
Tel No: (D) +91 120 433 0800,
United States: +1-201971-6302
